# 4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery

> **NCT02365935** · NA · COMPLETED · sponsor: **Campus Bio-Medico University** · enrollment: 215 (actual)

## Conditions studied

- Uterine Cervical Neoplasms

## Interventions

- **PROCEDURE:** Group A adjuvant chemotherapy
- **PROCEDURE:** Group B adjuvant chemotherapy
- **DRUG:** Cisplatin
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT02365935
- **Lead sponsor:** Campus Bio-Medico University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2013-01
- **Final completion:** 2014-09
- **Target enrollment:** 215 (ACTUAL)
- **Last updated:** 2015-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365935, "4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02365935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*